Aimmune Therapeutics, Inc.

Aimmune Therapeutics, a subsidiary of Nestlé Health Science, is a biopharmaceutical firm focused on the development of innovative therapies aimed at preventing, managing, and treating diseases related to food, gastrointestinal (GI) issues, and metabolic disorders. The company is dedicated to becoming a global leader in this field, particularly for patients who have limited or no existing treatment options. Aimmune operates under the principle that families should have access to standardized, scientifically validated treatments that are approved by regulatory bodies. This approach is intended to alleviate the daily challenges faced by patients and their families in managing these health conditions.

Driving directions from: